DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Join us in Washington, DC
June 15-19, 2025

Join us at the DIA 2025 Global Annual Meeting—the ultimate hub for industry visionaries, regulators, government leaders, academics, innovators, and patients. Set in the dynamic city of Washington DC, this premier event invites global stakeholders to unite, collaborate, and ignite transformation in the life sciences.

Register Now

Unlock Industry Savings

DIA 2025

Your Savings Start Here! Pre-sale tickets for Industry attendees are available for a limited time. Experience a unique, neutral environment designed to drive groundbreaking innovation and elevate patient outcomes on a global scale!

Join Us Today!

Customer Testimonials

"The DIA meeting is so incredibly valuable from a professional standpoint for the networking, the content…its really super valuable, it's a must-attend meeting."

— Jennifer Emerson, Head of Quality Analytics and Risk Management, Boehringler-Ingleheim

"The way that DIA's Global Annual Meeting is different from other industry events is that it offers something for everyone. It’s the most democratic congress or association to which I belong, there are colleagues from every aspect of bio-pharmaceutical product development, and you learn a lot and it's just a lot of fun."

— Meg Richards, Executive Director, Strategy, Penalgo

"I love the Global Annual Meeting because it does bring together different disciplines, different experts from industry, from academia, from regulators to address the topics at hand and to bring that and make that available to attendees. "

— Jeremy Jokinen, Vice President and Head of Safety Evidence and Science, BMS

项目委员会

  • Linda  Akunne, MPH
    Linda Akunne, MPH Chief, Project Management Staff, ORO, OND, CDER
    FDA, United States
  • Venkatraman  Balasubramanian, PhD, MBA
    Venkatraman Balasubramanian, PhD, MBA Healthcare and Life Sciences Strategic Advisor
    VB Insights, LLC, United States
  • Greg  Ball, PhD
    Greg Ball, PhD Safety Data Scientist
    ASAPprocess, United States
  • Amy  Bertha
    Amy Bertha Executive Director, Regulatory Policy and Science
    Bayer, United States
  • Sanghita  Bhattacharya, PhD
    Sanghita Bhattacharya, PhD Director Data Science , Feasibility and Analytics, Clinical Operations
    Johnson & Johnson Innovative Medicine, United States
  • Asia  Blackwell
    Asia Blackwell Consumer Safety Officer
    FDA, United States
  • Claire  Blanchette, PMP
    Claire Blanchette, PMP Executive Drug Development Program Leader
    Consultant, United States
  • Tywnia  Brewton
    Tywnia Brewton Executive Director, Human Resources
    Astellas , United States
  • James  Buchanan, PharmD
    James Buchanan, PharmD President
    Covilance LLC, United States
  • Mandy Kaur Budwal-Jagait, MSc
    Mandy Kaur Budwal-Jagait, MSc Head of GCP and Lead Senior GCP Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Meghana  Chalasani, MHA
    Meghana Chalasani, MHA Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
    FDA, United States
  • Joan  Chambers
    Joan Chambers Senior Consultant
    Tufts CSDD, United States
  • Rachel  Chasse, MS
    Rachel Chasse, MS Associate Director, Digital Science Strategy
    AbbVie, United States
  • Christine  Colvis, PhD
    Christine Colvis, PhD Director, Drug Development Partnership Programs
    National Center for Advancing Translational Sciences (NCATS), United States
  • Karen  Correa, PhD
    Karen Correa, PhD Vice President, Head of Global Clinical Operations
    Takeda, United States
  • Solange  Corriol-Rohou, DrMed, MD, PhD
    Solange Corriol-Rohou, DrMed, MD, PhD Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
    AstraZeneca , France
  • Stephanie Y. Crawford, PhD, MPH, MS
    Stephanie Y. Crawford, PhD, MPH, MS Professor, Pharmacy Systems, Outcomes and Policy
    University of Illinois at Chicago, United States
  • Alysha  Croker, PhD
    Alysha Croker, PhD Director, Centre for Policy, Pediatrics and International Collaboration, BRDD
    Health Canada, Canada
  • Victoria  DiBiaso, BSN, MPH, RN
    Victoria DiBiaso, BSN, MPH, RN Global Head, Patient Informed Development and Health Value Translation
    Sanofi, France
  • Megan  Doyle, JD, MPH
    Megan Doyle, JD, MPH Associate Vice President, Assistant General Counsel - Diagnostics
    Eli Lilly & Company, United States
  • Nancy A Dreyer, PhD, MPH, FISPE
    Nancy A Dreyer, PhD, MPH, FISPE Founder
    Dreyer Strategies LLC, United States
  • Joseph  Dustin
    Joseph Dustin Founder and Managing Partner
    eClinical Consulting, United States
  • Jennifer  Emerson, PhD, MPH, RN, PMP
    Jennifer Emerson, PhD, MPH, RN, PMP Head Quality Analytics & Risk Management
    Boehringer Ingelheim, Germany
  • Andrew  Emmett, MPH
    Andrew Emmett, MPH FDA Liaison | US Regulatory Policy and Global Intelligence
    Pfizer Inc, United States
  • Ron  Fitzmartin, PhD, MBA
    Ron Fitzmartin, PhD, MBA Senior Advisor, Office of Regulatory Operations, CBER
    FDA, United States
  • Celeste  Frankenfeld Lamm, PhD
    Celeste Frankenfeld Lamm, PhD Senior Director, Global Regulatory Affairs – CMC
    Merck Sharp & Dohme LLC , United States
  • Danielle  Friend Economo, PhD
    Danielle Friend Economo, PhD Senior Director, US Head Regulatory Policy and Intelligence
    Johnson & Johnson Innovative Medicine, United States
  • David  Fryrear, MS
    David Fryrear, MS Executive Vice President and Head of Quality Assurance
    Astellas, United States
  • Cheryl  Grandinetti, PharmD
    Cheryl Grandinetti, PharmD Associate Director for Clinical Policy, CDER/OC/OSI/DCCE
    FDA, United States
  • Courtney  Granville, PhD, MPH
    Courtney Granville, PhD, MPH Chief Scientific Officer
    GO2 For Lung Cancer, United States
  • Lani  Hashimoto
    Lani Hashimoto Associate Director, Patient Engagement
    Novartis Pharmaceuticals Corporation, United States
  • Sabine  Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Cammilla  Horta Gomes, MA, MPharm
    Cammilla Horta Gomes, MA, MPharm Latam Regulatory Policy Lead
    Roche, Brazil
  • Stacy  Hurt, MBA, MHA
    Stacy Hurt, MBA, MHA Chief Patient Officer
    Parexel , United States
  • Huong  Huynh, PhD
    Huong Huynh, PhD Director of Regulatory Science
    Critical Path Institute, United States
  • Emily (Xianghong)  Jing, PhD
    Emily (Xianghong) Jing, PhD Associate Director for Scientific Coordination, OBP, OPQ, CDER
    FDA, United States
  • Jeremy  Jokinen, PhD, MS
    Jeremy Jokinen, PhD, MS Vice President and Head, Safety Evidence and Sciences
    Bristol-Myers Squibb Company, United States
  • Dominique  Lagrave, PharmD
    Dominique Lagrave, PharmD Senior Vice President of Regulatory Innovation
    Accumulus Synergy, United States
  • Cathryn C Lee, MSN
    Cathryn C Lee, MSN Director, Office of Program Operations, PDIMS, OND, CDER
    FDA, United States
  • Jingyu (Julia)  Luan, PhD
    Jingyu (Julia) Luan, PhD Executive Regulatory Science Director, BioPharmaceuticals R&D
    AstraZeneca, United States
  • Demetra  Macheras, MBA
    Demetra Macheras, MBA Director, Regulatory Policy and Intelligence - Regulatory Affairs
    AbbVie, United States
  • Nicole  Mahoney, PhD
    Nicole Mahoney, PhD Executive Director US Regulatory Policy & Intelligence
    Novartis Pharmaceuticals Corporation, United States
  • Lindsay  McNair, MD, MPH, MS
    Lindsay McNair, MD, MPH, MS Principal Consultant
    Equipoise Consulting, United States
  • Melodi J McNeil, MS, RPh
    Melodi J McNeil, MS, RPh Director, Regulatory Policy and Intelligence
    AbbVie, United States
  • David  Meats
    David Meats Director, Regulatory Services Management
    Certara, United States
  • Timothe  Menard, PharmD, MSc
    Timothe Menard, PharmD, MSc Global Head, Quality Excellence Digital | Bioethics Coach (Data Ethics)
    F. Hoffmann-La Roche Ltd, Switzerland
  • Pallavi  Mishra-Kalyani, PhD, MS
    Pallavi Mishra-Kalyani, PhD, MS Deputy Division Director, DBV, OB, CDER
    FDA, United States
  • May F Mo, MBA, MS
    May F Mo, MBA, MS Executive Director, Biostatistics
    Amgen, United States
  • Monica  Munoz, PharmD, PhD
    Monica Munoz, PharmD, PhD Division Director, Division of Pharmacovigilance-I, OSE, CDER
    FDA, United States
  • Lauren  Oliva, PharmD, RPh
    Lauren Oliva, PharmD, RPh US Lead, Global Regulatory Policy
    Biogen, United States
  • Y. Veronica  Pei, MD, MEd, MPH
    Y. Veronica Pei, MD, MEd, MPH Acting Associate Director, Biomedical Informatics and Regulatory Review Science
    FDA, United States
  • Vada A. Perkins, DrSc, MSc
    Vada A. Perkins, DrSc, MSc Vice President, Global Head of Regulatory Intelligence & Policy
    Boehringer Ingelheim, United States
  • Ranjini  Prithviraj, PhD, PMP
    Ranjini Prithviraj, PhD, PMP Director, Global Medical Affairs, Publication Management
    Regeneron, United States
  • Kim  Ribeiro, MS
    Kim Ribeiro, MS
    United States
  • Margaret  Richards, PhD, MPH
    Margaret Richards, PhD, MPH Executive Director, Solutions
    Panalgo, United States
  • Elizabeth  Rosenkrands-Lange, MPH, MS
    Elizabeth Rosenkrands-Lange, MPH, MS Senior Director/ Head of US Regulatory Scientific Policy
    EMD Serono, Part of Merck KGaA, Darmstadt, Germany, United States
  • Cynthia  Rothblum-Oviatt
    Cynthia Rothblum-Oviatt Science Policy Analyst, Rare Disease Team, OND, CDER
    FDA, United States
  • Leslie  Sam
    Leslie Sam President
    Leslie Sam and Associates, LLC, United States
  • Earl  Seltzer, MBA
    Earl Seltzer, MBA Senior Director, Partnerships and Innovation
    CTI, United States
  • Anjali  Shah, PharmD
    Anjali Shah, PharmD Executive Director, Business Capabilities and Innovation, WWPS
    Bristol-Myers Squibb Company, United States
  • Nancy Pire Smerkanich, DrSc, MS
    Nancy Pire Smerkanich, DrSc, MS Assistant Professor Regulatory & Quality Sciences
    University of Southern California School of Pharmacy, United States
  • Elizabeth  Somers, MS
    Elizabeth Somers, MS Executive Director, Global Project and Alliance Management
    Merck Sharp & Dohme LLC, United States
  • Benjamin  Stevens, PhD, MPH
    Benjamin Stevens, PhD, MPH Director CMC Policy and Advocacy
    GlaxoSmithKline, United States
  • Nancy Linda Styple
    Nancy Linda Styple Project Management Leader
    Bayer AG, United States
  • Ling  Su, PhD
    Ling Su, PhD Research Fellow
    Shenyang Pharmaceutical University, Yeehong Business School, China
  • Alec  Thompson, PharmD, MS
    Alec Thompson, PharmD, MS Senior Product Manager, Oncology
    Gilead Sciences, United States
  • Michael  Torok, PhD
    Michael Torok, PhD Vice President, Global Head of Quality Assurance Programs
    Genentech, A Member of the Roche Group, United States
  • Phil  Tregunno
    Phil Tregunno Deputy Director - Patient Safety Monitoring
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • Yoshiaki  Uyama, PhD, RPh
    Yoshiaki Uyama, PhD, RPh Associate Executive Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • James  Valentine, JD, MHS
    James Valentine, JD, MHS Director
    Hyman, Phelps & McNamara, PC, United States
  • James  Wabby, MHS
    James Wabby, MHS Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
    AbbVie, United States
  • Paula  Walker, MA
    Paula Walker, MA Global Head of Risk Based Quality Management
    Roche Products Ltd., United Kingdom
  • Robin  Whitsell
    Robin Whitsell President
    Whitsell Innovations, Inc., United States
  • Amira  Younes
    Amira Younes Director, Global Regulatory Policy EEMEA
    MSD, United Arab Emirates
Load More

Stay Connected!

Sign up for our newsletter to get the latest updates, exclusive insights, and special offers delivered straight to your inbox. Be the first to know about upcoming events, new releases, and more. Join our community today!

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。